Status:
COMPLETED
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Organization to Achieve Solutions in Substance Abuse (OASIS)
Conditions:
Hepatitis C
Heroin Dependence
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
Detailed Description
This is a prospective pilot safety study based on the hypothesis that active, street-recruited heroin users can be successfully treated for hepatitis C after stabilization on buprenorphine. Eligible s...
Eligibility Criteria
Inclusion
- Active heroin or other illicit opioid use
- Active hepatitis C
- No medical or psychiatric contraindications
- Able to sign informed consent
Exclusion
- No opiate dependence
- Age \<18
- Unable or uninterested in attending weekly group sessions
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00249574
Start Date
June 1 2003
End Date
June 1 2006
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
O.A.S.I.S.
Oakland, California, United States, 94612